Skip to main content
Log in

Clozapine treatment increases serum glutamate and aspartate compared to conventional neuroleptics

  • Short Communication
  • Biological Psychiatry
  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary

To examine whether serum excitatory amino acid concentrations change with clozapine treatment and whether these changes correlate with improvement in negative symptoms, serum excitatory amino acids were measured and clinical scales administered in seven subjects with schizophrenia before and after switching from conventional neuroleptics to clozapine. Clozapine treatment was associated with increased serum glutamate and aspartate concentrations. Clinical improvement was negatively correlated with baseline glycine concentrations. These results support the hypothesis that clozapine acts at least in part by increasing glutamatergic activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Alfredsson G, Wiesel FA (1990) Relationships between clinical effects and monoamine metabolites and amino acids in sulpiride-treated schizophrenia patients. Psychopharmacology 101: 324–331

    Google Scholar 

  • Alfredsson G, Wiesel FA, Tylec A (1988) Relationships between glutamate and monoamine metabolites in cerebrospinal fluid and serum in healthy volunteers. Biol Psychiatry 23: 689–697

    Google Scholar 

  • Alfredsson G, Wiesel FA, Lindberg M (1988) Glutamate and glutamine in cerebrospinal fluid and serum from healthy volunteers-analytical aspects. J Chromatogr 424: 378–384

    Google Scholar 

  • Bakshi VP, Swerdlow NR, Geyer MA (1994) Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J Pharmacol Exp Ther 271: 787–794

    Google Scholar 

  • Corbett R, Camacho R, Woods AT, Kerman LL, Fishkin RJ, Brooks K, Dunn RW (1995) Antipsychotic agents antagonize non-competitive N-methyl-d-aspartate antagonist-induced behaviors. Psychopharmacology 120: 67–74

    Google Scholar 

  • Coyle JT (1996) The glutamatergic dysfunction hypothesis for schizophrenia. Harvard Rev Psychiatry 3: 241–253

    Google Scholar 

  • Daly DA, Moghaddam B (1993) Actions of clozapine and haloperidol on the extracellular levels of excitatory amino acids in the prefrontal cortex and striatum of conscious rats. Neurosci Lett 152: 61–64

    Google Scholar 

  • Farber NB, Price MT, Labruyere J, Nemnich J, St. Peter H, Wozniak DF, Olney JW (1993) Antipsychotic drugs blocks phencyclidine induced neurotoxicity. Biol Psychiatry 34: 119–121

    Google Scholar 

  • Goff DC, Tsai G, Manoach DS, Coyle JT (1995) Dose-finding trial of d-cycloserine added to neuroleptics for negative symptoms in schizophrenia. Am J Psychiatry 152: 1213–1215

    Google Scholar 

  • Goff DC, Tsai G, Manoach DS, Flood J, Darby DG, Coyle JT (1996) D-cycloserine added to clozapine for patients with schizophrenia. Am J Psychiatry 153: 1628–1630

    Google Scholar 

  • Kim JS, Kornhuber Fffl, Schmid-Burgk W, Holzmuller B (1980) Low cerebrospinal glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci Lett 20: 379–382

    Google Scholar 

  • Korpi ER, Kaufmann CA, Marnela KM, Weinberger DR (1987) Cerebrospinal fluid amino acid concentrations in chronic schizophrenia. Psychiatry Res 20: 337–345

    Google Scholar 

  • Lang A, Soosar A, Harro J (1992) The involvement of sigma and phencyclidine receptors in the action of antipsychotic drugs. Pharmacol Toxicol 71: 132–138

    Google Scholar 

  • McGale EHF, Pye IF, Stonier C, Hutchinson EC, Aber GM (1977) Studies of the interrelationship between cerebrospinal fluid and plasma amino acid concentrations in normal individuals. J Neurochem 29: 291–297

    Google Scholar 

  • Olney JW, Farber NB (1994) Efficacy of clozapine compared with other antipsychotics in preventing NMDA-antagonist neurotoxicity. J Clin Psychiatry 55: 43–46

    Google Scholar 

  • Olney JW, Farber NB (1995) Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52: 998–1007

    Google Scholar 

  • Tiedtke PI, Bischoff C, Schmidt WJ (1990) MK-801-induced stereotypy and its antagonism by neuroleptic drugs. J Neural Transm 81: 173–182

    Google Scholar 

  • Watson GB, Bolanowski MA, Baganoff MP, Deppeler CL, Lanthorn TH (1990) D-Cycloserine acts as a partial agonist at the glycine modulatory site of the NMDA receptor expressed in Xenopus oocytes. Brain Res 510: 158–160

    Google Scholar 

  • Yamamoto BK, Pehek EA, Meltzer HY (1994) Brain region effects of clozapine on amino acid and monoamine transmission. J Clin Psychiatry 55: 8–14

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Evins, A.E., Amico, E.T., Shih, V. et al. Clozapine treatment increases serum glutamate and aspartate compared to conventional neuroleptics. J. Neural Transmission 104, 761–766 (1997). https://doi.org/10.1007/BF01291892

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01291892

Keywords

Navigation